[
  {
    "ts": null,
    "headline": "ResMed Inc. stock rises Wednesday, outperforms market",
    "summary": "ResMed Inc. stock rises Wednesday, outperforms market",
    "url": "https://finnhub.io/api/news?id=cb5f109b8043c759f41e2e1d17aa210cd77a7f43089db6da2ebed29a6ec4cbff",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755103980,
      "headline": "ResMed Inc. stock rises Wednesday, outperforms market",
      "id": 136393509,
      "image": "",
      "related": "RMD",
      "source": "MarketWatch",
      "summary": "ResMed Inc. stock rises Wednesday, outperforms market",
      "url": "https://finnhub.io/api/news?id=cb5f109b8043c759f41e2e1d17aa210cd77a7f43089db6da2ebed29a6ec4cbff"
    }
  },
  {
    "ts": null,
    "headline": "Why ResMed (RMD) is a Top Momentum Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=0f11e213b0f7f1d8d8825e1b2884231a62ad0135ed1186dcb906ccab02c91718",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755093003,
      "headline": "Why ResMed (RMD) is a Top Momentum Stock for the Long-Term",
      "id": 136340041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=0f11e213b0f7f1d8d8825e1b2884231a62ad0135ed1186dcb906ccab02c91718"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From ResMed’s Q2 Earnings Call",
    "summary": "ResMed’s second quarter results were met with a positive market reaction, following revenue and non-GAAP profit figures that surpassed Wall Street expectations. Management attributed this performance to robust international demand for sleep and respiratory devices, ongoing operational efficiency initiatives, and strength in its ReSupply and software portfolios. CEO Michael J. Farrell emphasized the success of new product rollouts and the company’s disciplined investment in research and developme",
    "url": "https://finnhub.io/api/news?id=d030fddb184af96d7dc95f1152c88164ae2ec2f5f21265ccbca2108da32cd6f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755056197,
      "headline": "The Top 5 Analyst Questions From ResMed’s Q2 Earnings Call",
      "id": 136328668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed’s second quarter results were met with a positive market reaction, following revenue and non-GAAP profit figures that surpassed Wall Street expectations. Management attributed this performance to robust international demand for sleep and respiratory devices, ongoing operational efficiency initiatives, and strength in its ReSupply and software portfolios. CEO Michael J. Farrell emphasized the success of new product rollouts and the company’s disciplined investment in research and developme",
      "url": "https://finnhub.io/api/news?id=d030fddb184af96d7dc95f1152c88164ae2ec2f5f21265ccbca2108da32cd6f9"
    }
  },
  {
    "ts": null,
    "headline": "RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance",
    "summary": "Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=b73851549317d208272cc760b165ee6c5002956fe9581bff6c8e4b0076e2454a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755055252,
      "headline": "RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance",
      "id": 136328669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=b73851549317d208272cc760b165ee6c5002956fe9581bff6c8e4b0076e2454a"
    }
  }
]